57624 Federal Register / Vol. 78, No. 182 / Thursday, September 19, 2013 / Notices 

drugs have been limited to those drugs 

for which the beneficiary has a 

prescription for a drug in the same class 

and for which a clinically effective OTC 

drug is also available. The current 

demonstration is scheduled to end in 

November 2014. In the National Defense 

Authorization Act for Fiscal Year 2013, 

Congress authorized the Department to 

provide Over the Counter (OTC) drugs 

to beneficiaries under regulations 

prescribed by the Secretary. Although 

the Department could now cease the 

demonstration and implement this new 

Congressional authority, it is now 

considering the viability of adding some 

drugs, such as the Plan B One-Step 

(levonorgestrel) which is an OTC 

product for all women of child-bearing 

potential that does not require a 

prescription. It was decided that the 

most efficient method of testing this 

new criteria was by modification to the 

current demonstration. 

DATES: This demonstration project will 

continue through until November 30, 

2016 in order to provide adequate time 

to implement and evaluate the 

substantive changes allowing the DoD to 

provide drugs, such as the Plan B OneStep, that are in the class of drugs 

normally requiring a prescription but 

which the FDA has granted an 

exception to the prescription 

requirement. 

FOR FURTHER INFORMATION CONTACT: 

Captain Nita Sood, TRICARE 

Management Activity, Pharmaceutical 

Operations Directorate, telephone (703) 

681–2890. 

SUPPLEMENTARY INFORMATION: 

Background 

Section 705 of the John Warner 

National Defense Authorization Act for 

2007 directed the Secretary to conduct 

a demonstration project under 10 

United States Code (U.S.C.) 1092 to 

allow certain over-the-counter (OTC) 

medications to be included on the 

uniform formulary under 10 U.S.C. 

1074g. On June 15, 2007, the 

Department of Defense published a 

notice in the Federal Register (FR) (72 

FR 33208–33210) implementing the 

demonstration project until the 

implementation of the combined 

TRICARE mail and retail contract 

(TPharm) which was on November 4, 

2009. In order to more thoroughly 

evaluate the clinical and cost 

effectiveness of OTC drugs as well as 

beneficiary satisfaction with the project, 

the Department published a notice in 

the FR (74 FR 66626–66627) on 

December 16, 2009 that extended the 

demonstration project through 

November 4, 2012. The Department 

determined that continuation of the 

demonstration project for an additional 

2 years was necessary to provide the 

Secretary with sufficient information to 

fully evaluate the project. The 

demonstration project continues to be 

authorized by 10 U.S.C. 1092. Section 

702 of the National Defense 

Authorization Act for Fiscal Year 2013 

authorized the Department to provide 

OTC pharmaceuticals under terms 

prescribed by the Secretary. This 

authorization would allow the 

Department to implement its current 

demonstration under its current terms. 

These terms have been to authorize the 

provision of OTC drugs when the 

beneficiary had been receiving 

prescription drugs in the same class and 

a clinically effective OTC was available. 

These drugs were treated as generic 

prescription medications, except that 

the need for a prescription and/or a 

copay were waived. The OTC drugs 

must have been recommended by the 

DoD Pharmacy and Therapeutics 

Committee and approved by the 

Assistant Secretary of Defense, (Health 

Affairs) prior to inclusion on the 

formulary. On June 20, 2013, the Food 

and Drug Administration (FDA) 

announced the use of Plan B One-Step 

(levonorgestrel) emergency 

contraceptive as an over-the-counter 

product ‘‘for all women of child-bearing 

potential without age or point-of-sale 

restrictions.’’ Contraceptive drugs are a 

type of drug which normally would 

require a prescription prior to 

dispensing, however the FDA made an 

exception for this particular drug. The 

statute governing the Department’s 

pharmacy program, 10 U.S.C. 1074g, 

requires the Department to make 

available to its beneficiaries all 

prescription drugs approved by the 

FDA. The current issue for the 

Department regarding this drug, and any 

drugs for which the FDA might issue 

similar exceptions and mandates, is to 

determine how best to implement this 

requirement in our regulations. The 

modifications to the current 

demonstration are designed to help the 

Department determine whether these 

drugs can be treated in the same manner 

as the other OTC drugs which moved 

from prescription to non-prescription 

status. 

Modification of the Demonstration 

Project 

(1) Inclusion of the Over-the-Counter 

Plan B One-Step Emergency 

Contraceptive (levonorgestrel). 

(2) OTC availability of Plan B OneStep Emergency Contraceptive 

(levonorgestrel) through the 

demonstration project will be at retail 

dispensing venue. Eligibility includes 

all active duty service women and 

female beneficiaries of child-bearing 

potential, without age restrictions. All 

military treatment facility (MTF) 

pharmacies carry OTC Plan B One-Step, 

and provide it to all active duty service 

women and female beneficiaries of 

child-bearing potential, without age 

restrictions, at no cost. The OTC Plan B 

One-Step Emergency Contraceptive 

(levonorgestrel) will not be available 

through the demonstration project at the 

TRICARE mail order program because it 

would be clinically inappropriate to 

take OTC Plan B One-Step Emergency 

Contraceptive (levonorgestrel) after 72 

hours (3 days). 

(3) Eligible beneficiaries will not 

require a written prescription for Plan B 

One-Step Emergency Contraceptive 

(levonorgestrel). The beneficiary simply 

presents to the retail pharmacy and 

which will process the request 

identically to all other pharmacy claims. 

(4) Cost sharing requirements. The 

cost sharing will be zero copay. 

(5) Period of demonstration. The 

demonstration project will continue 

until November 30, 2016. 

Dated: September 16, 2013. 

Aaron Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2013–22833 Filed 9–18–13; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Department of the Army; Corps of 

Engineers 

Availability of a Draft Integrated 

Feasibility Report (Feasibility Study/

Environmental Impact Statement/

Environmental Impact Report), Los 

Angeles River Ecosystem Restoration 

Study, City of Los Angeles, Los 

Angeles County, CA 

AGENCY: Department of the Army, U.S. 

Army Corps of Engineers, DoD. 

ACTION: Notice of availability. 

SUMMARY: The U.S. Army Corps of 

Engineers (Corps) in conjunction with 

the City of Los Angeles (City) announces 

the availability of a Draft Integrated 

Feasibility Report (IFR), which includes 

a Draft Feasibility Study (FS) and 

Environmental Impact Statement/

Environmental Impact Report (EIS/EIR) 

for the Los Angeles River Ecosystem 

Restoration Study, Los Angeles County, 

CA, for review and comment. The study 

evaluates alternatives for the purpose of 

restoring 11 miles of the Los Angeles 

River from approximately Griffith Park 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 182 / Thursday, September 19, 2013 / Notices 57625 

to downtown Los Angeles while 

maintaining existing levels of flood risk 

management. Restoration includes 

creation and reestablishment of historic 

riparian strand and freshwater marsh 

habitat to support increased populations 

of wildlife and enhance habitat 

connectivity within the study area, as 

well as to provide opportunities for 

connectivity to ecological zones such as 

the Santa Monica Mountains, Verdugo 

Hills, Elysian Hills, and San Gabriel 

Mountains. Restoration also includes 

the reintroduction of ecological and 

physical processes such as a more 

natural hydrologic and hydraulic regime 

that reconnects the river to historic 

floodplains and tributaries, reduced 

flow velocities, increased infiltration, 

improved natural sediment processes, 

and improved water quality. The study 

also evaluates opportunities for passive 

recreation that is compatible with the 

restored environment. A Notice of Intent 

for the EIS/EIR was published on 

November 28, 2008 (73 FR 72455). 

DATES: The Draft IFR is available for a 

45-day review period from September 

20, 2013 through November 5, 2013 

pursuant to the National Environmental 

Policy Act (NEPA) and California 

Environmental Quality Act (CEQA). 

Written comments pursuant to the 

NEPA will be accepted until the close 

of public review at close of business on 

November 5, 2013. 

ADDRESSES: Questions or comments 

concerning the Draft IFR may be 

directed to: Josephine R. Axt, Ph.D.; 

Chief, Planning Division; U.S. Army 

Corps of Engineers; Los Angeles District; 

P.O. Box 532711; ATTN: Ms. Erin Jones, 

CESPL–PD–RN; Los Angeles, CA 

90053–2325 or comments.lariverstudy@

usace.army.mil. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Kathleen Bergmann, U.S. Army Corps of 

Engineers, Los Angeles District, 

Kathleen.M.Bergmann@usace.army.mil 

and Ms. Erin Jones, U.S. Army Corps of 

Engineers, Los Angeles District, 

Erin.L.Jones@usace.army.mil. 

SUPPLEMENTARY INFORMATION: As part of 

the public involvement process, notice 

is hereby given by the Corps Los 

Angeles District of a public meeting to 

be held at the Los Angeles River Center 

and Gardens (Atrium), 570 West Avenue 

26, Los Angeles, CA 90065 from 5:30 

p.m. to 7:30 p.m. on Thursday, October 

17, 2013. The public meeting will allow 

participants the opportunity to 

comment on the IFR. Attendance at the 

public hearing is not necessary to 

provide comments. Written comments 

may also be given to the contacts listed 

under ADDRESSES. 

The document is available for review 

at: 

(1) online at http://1.usa.gov/

1ad0K9z. 

(2) Arroyo Seco Regional Branch 

Library; 6145 N. Figueroa Street, Los 

Angeles, CA 90042; CD and Hard Copy. 

(3) Los Angeles Central Library; 630 

W 5th Street Los Angeles, CA 90071; CD 

and Hard Copy. 

(4) Atwater Village Branch Library; 

3379 Glendale Boulevard, Los Angeles, 

CA 90039; CD and Hard Copy. 

(5) Cypress Park Branch Library; 1150 

Cypress Avenue, Los Angeles CA 90065; 

CD. 

(6) Lincoln Heights Branch Library; 

2530 Workman Street, Los Angeles, CA 

90031; CD. 

(7) Chinatown Branch Library; 639 N. 

Hill Street, Los Angeles, CA 90012; CD. 

(8) Little Tokyo Branch Library; 203 S. 

Los Angeles Street, Los Angeles CA 

90012; CD. 

(9) Benjamin Franklin Branch Library; 

2200 E. First Street, Los Angeles, CA 

90033; CD. 

Kimberly M. Colloton, 

Colonel, U.S. Army, Commander and District 

Engineer. 

[FR Doc. 2013–22797 Filed 9–18–13; 8:45 am] 

BILLING CODE 3720–58–P 

DEPARTMENT OF ENERGY 

Federal Energy Regulatory 

Commission 

Combined Notice of Filings 

Take notice that the Commission has 

received the following Natural Gas 

Pipeline Rate and Refund Report filings: 

Filings Instituting Proceedings 

Docket Numbers: RP13–1323–000. 

Applicants: Questar Pipeline 

Company. 

Description: QPC Statement of Rates 

to be effective 8/10/2013. 

Filed Date: 9/11/13. 

Accession Number: 20130911–5097. 

Comments Due: 5 p.m. ET 9/23/13. 

Any person desiring to intervene or 

protest in any of the above proceedings 

must file in accordance with Rules 211 

and 214 of the Commission’s 

Regulations (18 CFR 385.211 and 

385.214) on or before 5:00 p.m. Eastern 

time on the specified comment date. 

Protests may be considered, but 

intervention is necessary to become a 

party to the proceeding. 

Filings in Existing Proceedings 

Docket Numbers: RP13–1223–002. 

Applicants: National Fuel Gas Supply 

Corporation. 

Description: Errata—ACA 2013— 

RP13–1223 to be effective 10/1/2013. 

Filed Date: 9/11/13. 

Accession Number: 20130911–5049. 

Comments Due: 5 p.m. ET 9/18/13. 

Any person desiring to protest in any 

of the above proceedings must file in 

accordance with Rule 211 of the 

Commission’s Regulations (18 CFR 

385.211) on or before 5:00 p.m. Eastern 

time on the specified comment date. 

The filings are accessible in the 

Commission’s eLibrary system by 

clicking on the links or querying the 

docket number. 

eFiling is encouraged. More detailed 

information relating to filing 

requirements, interventions, protests, 

service, and qualifying facilities filings 

can be found at: http://www.ferc.gov/

docs-filing/efiling/filing-req.pdf. For 

other information, call (866) 208–3676 

(toll free). For TTY, call (202) 502–8659. 

Dated: September 12, 2013. 

Nathaniel J. Davis, Sr., 

Deputy Secretary. 

[FR Doc. 2013–22747 Filed 9–18–13; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF ENERGY 

Federal Energy Regulatory 

Commission 

[Docket No. CP13–83–000] 

Arlington Storage Company, LLC; 

Notice of Availability of the 

Environmental Assessment for the 

Proposed Gallery 2 Expansion Project 

The staff of the Federal Energy 

Regulatory Commission (FERC or 

Commission) has prepared an 

environmental assessment (EA) for the 

Gallery 2 Expansion Project, proposed 

by Arlington Storage Company, LLC 

(Arlington) in the above-referenced 

docket. Arlington requests authorization 

to convert two existing salt caverns, 

known as Gallery 2, to natural gas 

storage at its Seneca Lake Storage 

facility in Schuyler County, New York. 

The conversion of the Gallery 2 caverns 

to natural gas storage would add 0.55 

billion cubic feet (Bcf) of working gas 

capacity, and 0.20 Bcf of base gas 

capacity to the Seneca Lake Storage 

facility, increasing the total working gas 

capacity from 1.45 Bcf to 2.0 Bcf. 

The EA assesses the potential 

environmental effects of the 

construction and operation of the 

Gallery 2 Expansion Project in 

accordance with the requirements of the 

National Environmental Policy Act 

(NEPA) of 1969. The FERC staff 

concludes that approval of the proposed 


tkelley on DSK3SPTVN1PROD with NOTICES